Pathologically activated fibroblasts have been shown to play a role in fibrotic disorders and cancer, but the molecular mechanisms regulating their emergence are still poorly characterized. A recent study demonstrates that unleashing metalloproteinase activity in fibroblasts is sufficient for the acquisition of an activated pro-tumorigenic phenotype.
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Stromal cells and extracellular matrix (ECM) molecules within the tumor -collectively defined as the tumor microenvironment [1] -participate in many of the hallmarks of cancer [2] . Cancer-associated fibroblasts (CAFs) are non-malignant cells found in many solid tumors that provide a chemical and physical microenvironment that can favor tumor aggressiveness and dissemination [3, 4] . Unlike normal fibroblasts, CAFs present a pathologically activated phenotype that is responsible for their pro-tumorigenic activities. This phenotype is also found in fibroblasts in fibrotic disorders and is reminiscent of the activated status observed in fibroblasts during wound healing. Despite the major role of CAFs in tumor progression and their influence in overall patient survival [3, 5] , the molecular rearrangements leading to the altered CAF state are not well understood. A new study by Shimoda et al. [6] now demonstrates that deletion of a family of metalloproteinase inhibitors is sufficient for the acquisition of an activated fibroblast phenotype that promotes cancer progression through the production of exosomes.
The metzincin superfamily of proteases comprises several families of endopeptidases that include matrix metalloproteinases (MMPs) and adamalysins (ADAM), among others. By influencing the ECM, cell-adhesion molecules and soluble factors, proteinases participate in many physiological and pathological processes [7] . Due to their potent activity on signaling and ECM remodeling, proteinases are tightly regulated at the transcriptional and post-translational levels. Tissue inhibitors of metalloproteinases (TIMPs) are one of the main regulators of metzincin proteases [8] . The roles of TIMPs in both normal development and pathological processes have been investigated by gene deletion studies in mice, revealing some functional redundancy between different TIMPs [9] .
To identify new fundamental functions mediated by TIMPs and to avoid any compensatory effects between different isoforms, Shimoda et al. [6] generated a mouse lacking all four Timp genes [6] . These quadruple Timp-deficient (TIMPless) mice showed widespread developmental problems that hindered any cancer study but that underline an essential role for TIMPs in normal development that will need to be explored in the future.
Due to the early lethality of TIMPless mice, primary dermal fibroblasts were derived and used throughout the study as a model to investigate the impact of TIMPs on fibroblast activation. Using a-smooth muscle actin (a-SMA) as readout, it was observed that only deletion of all Timp genes led to a significant activation. Timp1-4 loss in fibroblasts led to the acquisition of CAF-like features, as shown by increased collagen contractility and expression of activation markers, such as a-SMA, stromal-derived factor 1 (SDF-1) and transforming growth factor b2 (TGF-b2). Importantly, when co-injected with human breast, lung and head-and-neck cancer cells, TIMPless fibroblasts promoted primary tumor growth, angiogenesis and metastasis in vivo.
Pro-tumorigenic functions of CAFs have generally been associated with the production of ECM components or soluble factors [3, 4] . The findings by Shimoda et al. [6] highlight the importance of exosomes as a new mode of intercellular communication in tumor progression and complement recent studies demonstrating that fibroblast-secreted exosomes accelerate breast cancer metastasis through induction of Wnt-planar cell polarity signaling in cancer cells [10] . Exosomes are small vesicles that are constitutively released by exocytosis and that act as potent intercellular communicators, delivering proteins, mRNA and microRNAs to neighboring and distant cells [11] . The authors provide compelling evidence that exosomes produced by TIMPless fibroblasts were responsible for their increased tumorigenic abilities. In particular, treatment with exosomes derived from TIMPless fibroblasts enhanced cancer cell motility through RhoA activation, and induced cancer stem cell phenotypes via stimulation of Notch signaling (Figure 1) . A thorough characterization of the proteomic content of the exosomes produced by TIMPless and wild-type fibroblasts identified several proteins enriched in TIMPless exosomes. One specific factor -the transmembrane metalloproteinase ADAM10 -was found to be responsible for the pro-tumorigenic activities of the TIMPless exosomes because ADAM10 inhibition abrogated both RhoA and Notch activation induced by exosome treatment. Significantly, knocking down ADAM10 expression in TIMPless fibroblasts diminished their pro-tumorigenic and pro-metastatic potential in vivo.
Although the underlying mechanism behind the generation of ADAM10-enriched exosomes in response to Timp1-4 loss still needs clarification, the activity of these exosomes may have wider implications (Figure 1) . Exosomes produced by cancer cells have been shown to participate in the recruitment and modulation of other stromal cells, such as bone marrow progenitors and immune cells, both locally and systemically [12] . Whether TIMPless exosomes also interact with adjacent non-malignant cells is a possibility that merits further investigation. Both Notch signaling and Rho activation can regulate CAF activities [13, 14] , suggesting that ADAM10-enriched exosomes may contribute to the maintenance of a CAF phenotype and/or to the activation of adjacent normal fibroblasts. Mass spectrometry analysis showed that TIMPless exosomes are enriched in ECM proteins and ECM-modifying enzymes. Thus, exosomes may also modulate ECM composition, which, in turn, will subsequently affect other tumoral components. These activities may also be relevant in other scenarios where protease dysregulation and pathological fibroblast activation have been observed, such as fibrosis and inflammation. Furthermore, the activities of CAF-derived exosomes may not only be confined to the local environment but could also have systemic effects and participate in the conditioning of metastatic niches [12] . In support of this hypothesis, TIMPless exosomes are enriched in tenascin C, a glycoprotein that supports metastatic spread through niche formation [15] .
These findings from murine primary fibroblasts were in part recapitulated in clinical settings [6] . Analysis of CAFs derived from human head-and-neck squamous cell carcinoma indicated that they also produced ADAM10-rich exosomes. Similar to TIMPless fibroblasts, these exosomes activated RhoA and Notch signaling in cancer cells through their ADAM10 activity. No analysis of MMP, ADAM or TIMP gene expression was reported in this setting to clearly link the production of pro-tumorigenic exosomes to proteinase dysregulation. However, three different sets of CAFs isolated from lung cancer patients showed a robust downregulation of all four TIMP genes, suggesting that loss of TIMP in cancer stroma may contribute to the emergence and tumor-promoting abilities of CAFs in human disease.
Since independent genetic events targeting all four TIMPs are very unlikely in a clinical setting, a possible alternative for TIMP silencing in CAFs could be via epigenetic or post-translational modifications. Alternatively, non-cell-autonomous mechanisms may also operate and fibroblast activation may be driven by local variations in the extracellular levels of proteases and TIMPs, regardless of their origin. Further analysis will be required to explore these possibilities. Such studies would increase our understanding of the specific role of metalloproteinases in cancer progression and regulation of the tumor microenvironment. Considering that MMP intervention strategies have all failed in clinical trials [16] , these analyses could have important therapeutic implications.
The findings reported by Shimoda et al. [6] add to the current understanding of molecular regulators of CAF emergence, but they also raise new questions. In particular, detailed mechanistic description of the molecular events responsible for the CAF-like state after Timp1-4 deletion is needed. Enhanced proteinase activity can release latent growth factors and chemokines from the ECM [7] that may affect fibroblast activation. Alternatively, unleashing extracellular proteinase activity may lead to matrix stiffening, which has been shown to promote CAF emergence [17] . Moreover, TIMPs can also function by regulating key signaling pathways [7, 8] . Analysis of the signaling and transcriptional rearrangements in response to Timp1-4 deletion may assist in clarifying this point. A thorough characterization of these events will allow a more detailed investigation of the CAF-like phenotype, whilst integration of the adaptations elicited by Timp1-4 loss in relation to other CAF models [14, [17] [18] [19] [20] ] may increase our current understanding of CAF biology and lead to refined prognostic signatures, markers and targets to translate into the clinic. Figure 1 . TIMPless fibroblasts as multifunctional regulators of tumor progression through exosome production. Loss of Timp family members is sufficient for the acquisition of a CAF-like state in fibroblasts by unknown mechanisms (1, black arrow). TIMPless fibroblasts generate ADAM10-rich exosomes, which enhance cancer cell motility through RhoA activation and induce cancer stem cell phenotypes via Notch signaling stimulation (2, black arrow). In red, hypothetical functions of ADAM10-rich exosomes in the tumor microenvironment. ADAM10-rich exosomes may have local functions on normal or activated fibroblasts (3), paracrine activities on other stromal cell types (4), or regulate ECM composition and remodeling (5) and thereby have indirect effects over multiple tumor microenvironment components. ADAM10-rich exosomes may also have distant effects and contribute to the conditioning of pre-metastatic niches (6) . These functions may be dependent on their signaling or ECM-modifying capabilities.
